| Literature DB >> 30994724 |
Luisa Allen Ciuffo1,2, João Lima3, Henrique Doria de Vasconcellos2, Muhammad Balouch2, Susumu Tao2, Saman Nazarian2, David D Spragg2, Joseph E Marine2, Ronald D Berger2, Hugh Calkins2, Hiroshi Ashikaga2.
Abstract
BACKGROUND: Recent studies suggest that left atrial (LA) late gadolinium enhancement (LGE) can quantify the underlying tissue remodeling that harbors atrial fibrillation (AF). However, quantification of LA-LGE requires labor-intensive magnetic resonance imaging acquisition and postprocessing at experienced centers. LA intra-atrial dyssynchrony assessment is an emerging imaging technique that predicts AF recurrence after catheter ablation. We hypothesized that 1) LA intra-atrial dyssynchrony is associated with LA-LGE in patients with AF and 2) LA intra-atrial dyssynchrony is greater in patients with persistent AF than in those with paroxysmal AF.Entities:
Mesh:
Year: 2019 PMID: 30994724 PMCID: PMC6459423 DOI: 10.5935/abc.20190064
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Figure 3Left atrial (LA) late gadolinium enhancement cardiac magnetic resonance (CMR). A – B: anterior LA shell view with areas of enhancement (red). C – D: posterior LA shell view with areas of enhancement (red). E - F: quantification of LA enhancement by CMR using image intensity ratio (IIR). Left side (A, C, and E), individual with low enhancement – right side (B, D, and F), individual with high enhancement.
Figure 1Quantification of left atrial regional function using cine cardiac magnetic resonance. The figures show a total of 12 color-coded segments within the left atrium. A: Two-chamber view with six equal-length segments; B: Four-chamber view with six equal-length segments.
Figure 2Strain curves of all 12 segments. Green dots, standard deviation of the time to peak strain (SD-TPS) of each segment; Blue dots, standard deviation of the time to peak pre-atrial strain (SD-TPSpreA) of each segment.
Baseline characteristics
| Overall (n = 146) | Paroxysmal AF (n = 102) | Persistent AF (n = 44) | p | |
|---|---|---|---|---|
| Age, years | 60.0 ± 10.0 | 60.0 ± 10.1 | 59.7±9.8 | 0.906 |
| Body mass index, kg/m2 | 28.4 ± 5.5 | 28.0 ± 5.4 | 29.9 ± 5.3 | 0.073 |
| Male, n (%) | 102 (70.0) | 74 (72.5) | 28 (63.3) | 0.134 |
| Heart failure, n (%) | 14 (9.6) | 8 (7.8) | 6 (13.6) | 0.082 |
| Coronary artery disease/vascular disease, n (%) | 12 (8.2) | 10 (9.8) | 2 (4.5) | 0.536 |
| Diabetes, n (%) | 15 (15.4) | 12 (11.8) | 3 (6.8) | 0.704 |
| Hypertension, n (%) | 60 (41.1) | 42 (41.2) | 18 (40.9) | 0.154 |
| History of stroke/TIA, n (%) | 9 (6.2) | 8 (7.8) | 1 (2.3) | 0.351 |
| CHA2DS2-VASC | 1.60 ± 1.5 | 1.5 ± 1.6 | 1.6 ± 1.2 | 0.942 |
| Obstructive sleep apnea, n (%) | 23 (15.8) | 17 (16.7) | 6 (13.6) | 0.796 |
| Ablation strategy (cryoablation), n (%) | 34 (23.3) | 28 (27.5) | 6 (13.6) | 0.324 |
| ACEI/ARBS, n (%) | 37 (25.3) | 24 (23.5) | 13 (29.5) | 0.389 |
| Beta-blockers, n (%) | 81 (56.3) | 62 (60.8) | 19 (43.2) | 0.788 |
| Calcium-channel blockers, n (%) | 33 (22.9) | 26 (25.5) | 7 (15.9) | 0.637 |
| Number of antiarrhythmic drugs | 1.2 ± 0.8 | 1.2 ± 0.8 | 1.4 ± 0.7 | 0.108 |
Data are presented as mean ± standard deviation, n (%), or median. AF: atrial fibrillation; TIA: transient ischemic attack; ACEI/ARB: angiotensin-converting enzyme inhibitor/angiotensin receptor blockers; CHA2DS2-VASC: score for stroke risk assessment in atrial fibrillation.
Left atrial (LA) functional parameters by groups
| Paroxysmal AF (n = 102) | Persistent AF (n = 44) | p | |||
|---|---|---|---|---|---|
| Mean | 95% CI | Mean | 95% CI | ||
| Minimum LA volume index, mm3/m2 | 19.0 ± 7.8 | 18.5 - 21.4 | 23.0 ± 10.1 | 19.5 - 26.5 | 0.062 |
| Maximum LA volume index, mm3/m2 | 38.8 ± 10.5 | 36.8 - 40.8 | 39.6 ± 11.7 | 35.6 - 43.7 | 0.691 |
| Total LAEF, % | 49.5 ± 10.0 | 47.6 - 51.4 | 44.0 ± 12.6 | 39.6 - 48.3 | 0.008 |
| Passive LAEF, % | 22.9 ± 7.3 | 21.6 - 24.3 | 20.7 ± 8.3 | 17.8 - 23.5 | 0.128 |
| Active LAEF, % | 34.6 ± 10.8 | 32.5 - 36.6 | 29.5 ± 14.1 | 24.6 - 34.3 | 0.026 |
| Smax, % | 28.9 ± 8.9 | 27.2 - 30.5 | 26.0 ± 11.8 | 22.0 - 30.1 | 0.132 |
| SR | 1.1 ± 0.4 | 1.1 - 1.2 | 1.1 ± 0.5 | 0.9 - 1.3 | 0.347 |
| SRe | -1.1 ± 0.5 | -1.2 - -1.0 | -0.8 ± 0.4 | -1.0 - -0.7 | 0.010 |
| SRa | -1.4 ± 0.5 | -1.5 - -1.3 | -1.1 ± 0.6 | -1.3 - -0.9 | 0.011 |
| LVEF, % | 58.4 ± 6.0 | 57.0 - 59.8 | 53.4 ± 10.3 | 49.4 - 57.4 | 0.004 |
| Mean TPS, ms | 397.8 | 374.5 - 420.2 | 403.5 | 369.9 - 429.0 | 0.538 |
| SD-TPS, % | 2.9 | 2.1 - 3.9 | 3.6 | 2.3 - 4.9 | 0.036 |
| Log - SD-TPS, % | 1.0 | 0.7 - 1.4 | 1.1 | 0.8 - 1.6 | 0.036 |
| Mean SD-TPSpreA, ms | 795.3 | 692.4 - 884.9 | 846.7 | 760.6 - 967.4 | 0.046 |
| SD-TPSpreA, % | 4.6 | 3.0 - 8.6 | 3.7 | 2.9 - 5.4 | 0.227 |
| Log - SD-TPSpreA, % | 1.5 | 1.1 - 2.2 | 1.3 | 1.1 - 1.7 | 0.177 |
| LGE extent (% LA surface) | 11.6 | 6.0 - 17.6 | 13.8 | 7.6 - 28.4 | 0.061 |
| Log LGE extent (% LA surface) | 2.4 | 1.8 - 2.9 | 2.6 | 2.0 - 3.3 | 0.061 |
Data are presented as median (interquartile range [IQR]) or mean ± standard deviation (SD). CI: confidence interval; LAEF: LA emptying fraction; Smax: maximum longitudinal LA strain; SR: peak longitudinal strain rate; SRe: early diastolic strain rate; SRa: late diastolic strain rate; LVEF: left ventricular ejection fraction; TPS: time to peak strain; TPSpreA: time to peak pre-atrial contraction strain; LGE: late gadolinium enhancement
Univariable and multivariable analyses
| Model 1 | Model 2 | Model 3 | ||||
|---|---|---|---|---|---|---|
| β | p | β | p | β | p | |
| Log SD-TPS, % | 0.66 | < 0.001 | 0.57 | 0.001 | 0.60 | 0.001 |
| Log SD-TPSpreA, % | 0.19 | 0.034 | 0.21 | 0.020 | 0.18 | 0.045 |
Model 2, adjusted for age, sex, type of atrial fibrillation, body mass index, history of cardiac failure, hypertension, obstructive sleep apnea. Model 3, covariables included in Model 2 in addition to minimum left atrial volume and maximum longitudinal strain. Vmin: minimum left atrial volume; Smax: maximum longitudinal strain; SD: standard deviation; TPS: time to peak strain; TPSpreA: time to peak pre-atrial contraction strain.
Figure 4Association between left atrial (LA) intra-atrial dyssynchrony and LA late gadolinium enhancement (LA-LGE). A, regression between LA-LGE and the standard deviation of the time to peak strain (SD-TPS); B, regression between LA-LGE and the standard deviation of the time to peak pre-atrial strain (SD-TPSpreA). Blue line, linear regression line. Log: logarithmically transformed variables; SD: standard deviation.
Inter-reader and intra-reader reproducibility of the left atrial measurements. Results are reported as mean ± standard deviation
| SD-TPS, % | -0.05 ± 0.21 | 0.86 | < 0.001 |
| SD-TPSpreA, % | -0.09 ± 0.83 | 0.74 | < 0.001 |
| SD-TPS, % | 0 ± 0.25 | 0.86 | < 0.001 |
| SD-TPSpreA, % | -0.03 ± 0.73 | 0.85 | < 0.001 |
LA: left atrial; SD: standard deviation; ICC: intraclass correlation coefficient; TPS: time to peak strain; TPSpreA: time to peak pre-atrial contraction strain.
Figure 5Intra-reader and inter-reader reproducibility – Bland-Altman plot. A, standard deviation of the time to peak strain (SD-TPS) intra-reader reproducibility. B, standard deviation of the time to peak pre-atrial strain (SD-TPSpreA) intra-reader reproducibility. C, SD-TPS inter-reader reproducibility. D, SD-TPSpreA inter-reader reproducibility. R1: first reader; R2: second reader.